Capital World Investors Novo Cure LTD Call Options Transaction History
Capital World Investors
- $625 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
262Shares Held
77MCall Options Held
1.17MPut Options Held
318K-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$202 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA7.92MShares$135 Million0.02% of portfolio
-
Nordwand Advisors, LLC Radnor, PA3.03MShares$51.8 Million12.67% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.81MShares$48 Million0.03% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.79B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...